Wu, Larisa
114  Ergebnisse:
Personensuche X
?
2

Profiling the process development of Wurster coating for mo..:

Wang, Zhouxi ; Yu, Xiang ; Wu, Larisa...
International Journal of Pharmaceutics.  625 (2022)  - p. 122053 , 2022
 
?
3

FDA's new pharmaceutical quality initiative: Knowledge-aide..:

Yu, Lawrence X. ; Raw, Andre ; Wu, Larisa...
International Journal of Pharmaceutics: X.  1 (2019)  - p. 100010 , 2019
 
?
4

Scientific Considerations in the Approval of Complex Generi..:

, In: The Science and Regulations of Naturally Derived Complex Drugs; AAPS Advances in the Pharmaceutical Sciences Series,
Raw, Andre S. ; Wu, Larisa - p. 157-173 , 2019
 
?
5

Regulatory Landscapes for Approval of Naturally-Derived Com..:

, In: The Science and Regulations of Naturally Derived Complex Drugs; AAPS Advances in the Pharmaceutical Sciences Series,
Wu, Larisa C. ; Raw, Andre ; Knöss, Werner... - p. 17-44 , 2019
 
?
6

Building parity between brand and generic peptide products:..:

Wu, Larisa C. ; Chen, Fu ; Lee, Sau L...
International Journal of Pharmaceutics.  518 (2017)  1-2 - p. 320-334 , 2017
 
?
8

FDA's new pharmaceutical quality initiative: Knowledge-aide..:

Yu, Lawrence X ; Raw, Andre ; Wu, Larisa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733282/.  , 2019
 
?
 
?
12

FDA's new pharmaceutical quality initiative: Knowledge-aide..:

Lawrence X. Yu ; Andre Raw ; Larisa Wu...
http://www.sciencedirect.com/science/article/pii/S2590156719300246.  , 2019
 
?
15

Simoctocog alfa (Nuwiq®) in previously untreated patients w..:

Mathias, Mary ; Abraham, Aby ; Belletrutti, Mark J....
European Journal of Haematology.  111 (2023)  4 - p. 544-552 , 2023
 
1-15